SCHEMBL1332785

SCHEMBL1332785

C=C(C)C(=O)Nc1ccc(-n2c3ccccc3c3ccccc32)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.51
▸ MAPT P10636 3/20 0.51
▸ RXFP1 Q9HBX9 1/20 0.49
▸ LMNA P02545 2/20 0.46
▸ POLB P06746 2/20 0.45
▸ L3MBTL1 Q9Y468 3/20 0.44
▸ ATM Q13315 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ HTT P42858 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ HDAC4 P56524 1/20 0.40
▸ TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12991152 0.92 MAPT (0.45) KDM4EMAPTRXFP1LMNAPOLB
SCHEMBL13127423 0.91 MAPT (0.44) KDM4EMAPTRXFP1LMNAPOLB
SCHEMBL12036885 0.89 KDM4E (0.42) KDM4EMAPTRXFP1LMNAPOLB
SCHEMBL12057407 0.82 TSPO (0.43) KDM4EMAPTLMNATDP1ALDH1A1
SCHEMBL12036827 0.81 TSPO (0.42) KDM4EMAPTLMNAPOLBL3MBTL1
SCHEMBL30557701 0.80 KDM4E (0.57) KDM4EMAPTLMNAPOLBL3MBTL1
SCHEMBL28912383 0.80 KDM4E (0.57) KDM4EMAPTLMNAPOLBL3MBTL1
SCHEMBL12991095 0.79 LMNA (0.38) KDM4EMAPTLMNAL3MBTL1NPSR1
SCHEMBL12991205 0.77 MAPT (0.59) KDM4EMAPTLMNAPOLBL3MBTL1
SCHEMBL439393 0.77 RXFP1 (0.74) KDM4EMAPTRXFP1POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110281388-A1 Cross-Linked Quantum Dots and Methods for Producing and Using the Same HCF PARTNERS, LP (US) 2011-11-17 — — US disclosed
US-20110245429-A1 Cross Linked Organic Conductive Layer GOUGH, NEIL (GB) 2011-10-06 — — US disclosed
US-20110245429-A1 Cross Linked Organic Conductive Layer GOUGH, NEIL (GB) 2011-10-06 — — US disclosed
US-20110245429-A1 Cross Linked Organic Conductive Layer GOUGH, NEIL (GB) 2011-10-06 — — US disclosed
US-20100308754-A1 Hole Transport Polymer for Use in Electronic Devices HCF PARTNERS, LP (US) 2010-12-09 — — US disclosed
US-20100308754-A1 Hole Transport Polymer for Use in Electronic Devices HCF PARTNERS, LP (US) 2010-12-09 — — US disclosed
US-20100308754-A1 Hole Transport Polymer for Use in Electronic Devices HCF PARTNERS, LP (US) 2010-12-09 — — US disclosed
CN-101903345-A Be used in the hole transport polymer in the electron device HCF PARTNERS LP 2010-12-01 — — CN disclosed
EP-2215060-A1 HOLE TRANSPORT POLYMER FOR USE IN ELECTRONIC DEVICES Dynamic Organic Light, Inc. (US) 2010-08-11 — — EP disclosed
WO-2010068205-A1 CROSS LINKED ORGANIC CONDUCTIVE LAYER HCF PARTNERS, L.P. (US) 2010-06-17 — — WO disclosed
WO-2010068205-A1 CROSS LINKED ORGANIC CONDUCTIVE LAYER HCF PARTNERS, L.P. (US) 2010-06-17 — — WO disclosed
WO-2009061314-A1 HOLE TRANSPORT POLYMER FOR USE IN ELECTRONIC DEVICES DYNAMIC ORGANIC LIGHT, INC. (US) 2009-05-14 — — WO disclosed
WO-2009061314-A1 HOLE TRANSPORT POLYMER FOR USE IN ELECTRONIC DEVICES DYNAMIC ORGANIC LIGHT, INC. (US) 2009-05-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245429-A1 Cross Linked Organic Conductive Layer GJB2, GJA1, KCNH3 KDM4E 864/4885MAPT 1700/4885RXFP1 4799/4885
US-20110281388-A1 Cross-Linked Quantum Dots and Methods for Producing and Using the Same MTCL3, DUOX2, NQO2 KDM4E 1968/4885MAPT 1266/4885RXFP1 3905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback